No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
US OptionsDetailed Quotes
CYRX240719P7500
- 0.75
- -0.15-16.67%
15min DelayClose Jun 28 16:00 ET
0.75High0.75Low
0.75Open0.90Pre Close1 Volume15 Open Interest7.50Strike Price75.00Turnover85.60%IV2.32%PremiumJul 19, 2024Expiry Date0.59Intrinsic Value100Multiplier19DDays to Expiry0.16Extrinsic Value100Contract SizeAmericanOptions Type-0.6186Delta0.2792Gamma7.68Leverage Ratio-0.0128Theta-0.0024Rho-4.75Eff Leverage0.0061Vega
Intraday
- 5D
- Daily
News
It's Down 28% But Cryoport, Inc. (NASDAQ:CYRX) Could Be Riskier Than It Looks
To the annoyance of some shareholders, Cryoport, Inc. (NASDAQ:CYRX) shares are down a considerable 28% in the last month, which continues a horrid run for the company. The recent drop completes a d
ResMed, Coinbase Global, Nvidia And Other Big Stocks Moving Lower On Monday
U.S. stocks were mixed, with the Dow Jones index gaining around 300 points on Monday.Shares of ResMed Inc. (NYSE:RMD) fell sharply during Monday's session following sleep apnea data from Lilly.Citigro
Express News | Cryoport Inc : Leerink Partners Cuts Target Price to $15 From $17
Cryoport and Minaris Regenerative Medicine Form Strategic Partnership to Support Advancement of Cell and Gene Therapies
Partnership Will Provide Cell and Gene Therapy Industry with Fully Integrated Logistics and Manufacturing Services for Regenerative Medicine Products
Is Cryoport (NASDAQ:CYRX) A Risky Investment?
The external fund manager backed by Berkshire Hathaway's Charlie Munger, Li Lu, makes no bones about it when he says 'The biggest investment risk is not the volatility of prices, but whether you will
Insider Sale: Director Richard Berman Sells 8,105 Shares of CryoPort Inc (CYRX)
Comments
Despite Cryoport's superior revenue outlook, its P/S ratio is not reflecting this positive outlook, suggesting that the market may be pricing in some risks. If the analysts' forecasts are accurate, the stock could be undervalued at its current price.
Cryoport, Inc.'s (NASDAQ:CYRX) Shares Not Telling The Full StoryInsider selling at Cryoport, Inc. over the past year, especially in recent months, may worry shareholders. However, significant insider ownership indicates alignment with other shareholders. The absence of insider buying in the last three months is noteworthy.
Cryoport's debt levels appear manageable, given healthy cash reserves and short-term assets. However, meeting future obligations will hinge on its profitability, an area where the company's performance has faltered. Cryoport saw modest revenue growth and a cash outflow last year.
$AMN Healthcare Services(AMN.US$ $CBL International(BANL.US$ $Chanson International(CHSN.US$ $Cryoport(CYRX.US$ $MetLife(MET.US$ $MillerKnoll(MLKN.US$ $Nova Lifestyle(NVFY.US$ $InspireMD(NSPR.US$ $Paramount Global-B(PARA.US$ $Ryder System(R.US$ $Recursion Pharmaceuticals(RXRX.US$ $Silk Road Medical(SILK.US$ $60 Degrees Pharmaceuticals(SXTP.US$ $Uber Technologies(UBER.US$ $Victory Capital(VCTR.US$
1
Read more